This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Biotech- and healthcare-related startups led the way as those companies dominate the list, taking a vast majority of spots. DDN , $300M, data storage: Data is the big-money game right now. Of course this is far from the only play the Blackstone Group has made in the data sector. billion to develop data centers in Spain.
Earlier this week, life sciences venture firm Dimension Capital announced it had raised a new $500 million second fund just two years after its first to hunt for startups that are using artificialintelligence to develop new medicines. Venture funding to AI-related biotech and healthcare startups hit only $4.8
startups raised half a billion dollars apiece, and another eight raised $100 million or more, with industries from cybersecurity to biotech to AI represented. The company is a so-called “neocloud” — a data center firm providing outsourced cloud computing for those looking to build AI. billion in over 900 rounds, per Crunchbase data.
Commerce Department said Wednesday it is imposing new export controls on biotechnology equipment and related technology because of national security concerns tied to artificialintelligence and data science. imposing new export controls on biotech equipment over China concerns appeared first on OODAloop.
Lambda , $480M, artificialintelligence: Lambda, which offers cloud computing services and hardware for training artificialintelligence software, raised a $480 million Series D co-led by Andra Capital and SGW. Founded in 2013, NinjaOne has raised nearly $762 million, per Crunchbase. billion valuation. billion valuation.
The surge was driven by large funds leading supergiant rounds in capital-intensive businesses in areas such as artificialintelligence, data centers and energy. The second-largest sector, healthcare and biotech, raised around $5.6 Data reported is as of Nov. OpenAI raised the largest round last month, a $6.6
As a business executive who has led ventures in areas such as space technology or data security and helped bridge research and industry, Ive seen first-hand how rapidly deep tech is moving from the lab into the heart of business strategy. Even terrestrial industries gain from enhanced communication and data from space.
Healthcare startups using artificialintelligence have come out of the gate hot in the new year when it comes to fundraising. Related reading: The Weeks Biggest Funding Rounds: Data Storage And Lots Of Biotech Illustration: Dom Guzman The round was led by Kleiner Perkins.
OpenAI , $6.6B, artificialintelligence: OpenAI announced its long-awaited raise of $6.6 The company is a so-called “neocloud” — a data center firm providing outsourced cloud computing for those looking to build AI. The startup builds artificialintelligence software for programmers. billion, per Crunchbase.
billion globally went to companies applying advances in artificialintelligence to health-related areas such as medical services and pharmaceutical development, per Crunchbase data. The smash hit of the past year was Tempus AI , an artificialintelligence precision medicine company that went public in June.
Data is the big-money game right now. Private equity giant Blackstone Group is making a $300 million strategic investment into DDN , valuing the Chatsworth, California-based data storage company at $5 billion. Big money Of course this is far from the only play the Blackstone Group has made in the data sector.
Venture money wasnt concentrated in just one sector, as VCs invested in everything from artificialintelligence to biotech to energy. tied) Anthropic , $1B, artificialintelligence: Anthropic, a ChatGPT rival with its AI assistant Claude, is reportedly taking in a fresh $1 billion investment from previous investor Google.
Understanding the Unique Challenges in Recruiting for Biotech and Life Sciences The recruitment process in the biotech and life sciences industry comes with its own set of unique challenges. One of the primary obstacles is the need for more highly skilled and qualified talent.
Biotech offerings, while more plentiful, are also running well below prior highs. Below, we pick out winners and losers for venture-backed tech and biotech companies, focusing on large- and medium-sized IPOs. Top biotech performers Biotech companies that debuted on public markets this year also saw plenty of ups and downs.
While some things tend to slow as the year winds down, artificialintelligence fundraising apparently isn’t one of them. xAI , $5B, artificialintelligence: Generative AI startup xAI raised $5 billion in a round valuing it at $50 billion, The Wall Street Journal reported. Let’s take a look. billion in 2021.
Overall startup funding in 2024 reached close to $314 billion compared to $304 billion in 2023 up around 3%, based on an analysis of Crunchbase data. Close to a third of all global venture funding went to companies in AI-related fields, making artificialintelligence the leading sector for funding. billion invested a year ago.
artificialintelligence. Hightouchs AI Decisioning product allows marketers to synchronize data and then let AI agents decide what messages and/or experiences to send each customer personalizing the marketing effort. Founded in 2018, the company has raised $172 million, per Crunchbase.
xAI , $5B, artificialintelligence: Generative AI startup xAI raised $5 billion in a funding round valuing it at $50 billion, The Wall Street Journal reported. Anthropic , $4B, artificialintelligence: Amazon has agreed to invest another $4 billion in AI startup Anthropic — a ChatGPT rival with its AI assistant Claude.
It was reported MGX a $100 billion artificialintelligence-focused investment vehicle founded by sovereign wealth fund Mubadala and Abu Dhabi-based AI company G42 plans to contribute about $7 billion to the new Stargate Project. However, that is nothing new for the firm when it comes to large AI investments in the U.S.
Nexthop AI , $110M, artificialintelligence: Artificialintelligence infrastructure provider Nexthop AI raised a massive $110 million round led by Lightspeed Venture Partners. Founded in 2012, the company has raised nearly $241 million, per Crunchbase.
Genomic data is considered to be the key to unlocking so-called “precision medicine” Some estimates suggest that by 2025, 500 million human genomes will have been sequenced, but only a fraction of it is being utilized for drug discovery and precision medicine. Privacy issues are regularly raised around genomic data.
Insilico Medicine, a Hong Kong-based company that has been using artificialintelligence to discover new drugs since 2014, has completed a fresh round of funding. This presents an opportunity for Insilico Medicine to emerge as a winner during the biotech spring.”
The appetite for genomic data continues to rise in the field of biotech and pharmaceutical research, but cost is still a factor — even sequencing a full genome now costs as little as $1,000. I asked Almogy what he felt were the areas of the biotech and medical industry that will benefit most from this new capability.
Suggestions like “listen to your customers” and “make data-driven decisions” are so general, they’re hard to implement. “While excessive or unhelpful customer data can clog content pipelines, the right information can power hyper-personalization at scale,” he writes.
The week was especially good for biotech, which led the way with two big raises. Tome Biosciences , $213M, biotech: A big biotech raise hit high on the list this week. Bicara Therapeutics , $165M, biotech: If Bicara Therapeutics looks familiar, it’s because this isn’t its first time on this list.
However, this week it was clearly biotech leading the way, with three startups from the sector nabbing spots in the top five. Alumis , $259M, biotech: This week saw the biggest biotech raise of the year thus far. While this was the biggest biotech raise of the week, it is by no means the only one on this list.
In addition to biotech, Russek felt there also needed to be software and automation components. Then there is the software aspect that enables remote operation management of the production and workflow mapped out with data so that it is easier to train and perform the farming tasks. So they created Atarraya, a U.S.-based
So, I ended up getting my master’s in computer engineering and specializing in data assurance and forensics. That’s where my love of security also began: Learning how data is important, how data belongs to the owner and how it should be protected…especially with the other mission of digitalization. Then I started working.
Digital drug discovery in general means large-scale analysis of biological data like genes, gene expression, protein structures, binding sites, things like that. So a new crop of biotech companies have worked to integrate these aspects. .” 2021 should be a banner year for biotech startups that make smart choices early.
billion — the highest amount invested at this stage in two years — that increase was concentrated in larger fundings and in two leading sectors — healthcare/biotech and AI. Bottleneck at Series A Since the second half of 2022, we found a Series A bottleneck based on an analysis of Crunchbase data. While total funding reached $31.5
We are at a similar inflection point in healthcare, with the recent movement toward data transparency birthing a new generation of innovation and startups. Anonymized data is much more freely available, while personal data is being locked even tighter (as it should be) due to regulations like GDPR, CCPA and their equivalents around the world.
Data needs to be stored somewhere. However, data storage costs keep growing, and the data people keep producing and consuming can’t keep up with the available storage. According to Internet Data Center (IDC) , global data is projected to increase to 175 zettabytes in 2025, up from 33 zettabytes in 2018.
Just three years after its founding, biotech startup Immunai has raised $60 million in Series A funding, bringing its total raised to over $80 million. “I hope it doesn’t sound corny, but we don’t have the luxury to move more slowly,” explained Immunai co-founder and CEO Noam Solomon in an interview.
Pika , $80M, artificialintelligence: It never takes us long to get to an AI startup on this list. Pika, an artificialintelligence startup that generates video, raised an $80 million round led by Spark Capital that values the Palo Alto, California-based company at $470 million, per Bloomberg.
Aside from that, the week saw some big rounds from cybersecurity, travel and of course, biotech. Just last month, Helsing , which develops artificialintelligence software for defense, raised approximately $489 million in funding led by General Catalyst that values the company at $5.4 billion in 2024, per Crunchbase data.
OpenAI , $6.6B, artificialintelligence: OpenAI announced its long-awaited raise of $6.6 Poolside , $500M, artificialintelligence: Most weeks a half-billion-dollar round would top this list — but this isn’t most weeks. The startup builds artificialintelligence software for programmers.
based AI companies, an analysis of Crunchbase data shows. Healthcare and biotech was the third-highest sector for new unicorns with nine companies. The number of new unicorn companies ticked up in 2024, driven largely by U.S.-based The Crunchbase Unicorn Board added 110 companies globally last year, up from 100 in 2023, with the U.S.
Biotech and AI had another strong week, as the sectors saw two big nine-figure rounds each — including one for $370 million in biotech. Candid Therapeutics , $370M, biotech: Every week there’s a big biotech raise — and this week there’s one that’s really big. Check out last week’s biggest funding rounds here.
xAI , $6B, artificialintelligence: Elon Musk ’s generative AI startup, xAI , officially announced its long-awaited fundraise — making it the second-most-valuable generative AI company in the world behind only competitor OpenAI. Grok is trained off data from another one of Musk’s companies, X, formerly Twitter. billion so far.
Finally, Astera Labs which provides data and memory connectivity solutions for some of the biggest chipmakers in the world had a successful IPO even though its shares have tailed off its highs. The startup gives access to the highly sought after AI chips from Nvidia through its more than two dozen data centers.
Kiteworks’ platform allows customers to share sensitive data with other trusted parties via communication channels such as email and file sharing. The company was formerly known as Accellion and suffered a major data breach in 2021. In 2020 the company raised $120 million in a funding round led by Bregal Sagemount.
AI, biotech, space tech and cybersecurity also saw good-sized raises. AlphaSense , $650M, artificialintelligence: AI-driven market intelligence platform AlphaSense raised $650 million in funding co-led by Viking Global Investors and BDT & MSD Partners at a $4 billion valuation — a 75% increase from just nine months ago.
Years before he co-launched a stealthy business to fix the messy world of health data, Gaurav Kaushik was slowly connecting the dots on how better visualization could impact health outcomes. Now, ScienceIO is not the first startup to try to fix healthcare data. ” Can API vendors solve healthcare’s data woes?
After a quiet holiday week, investors were back in action dishing out big rounds to startups in robotics, biotech, healthcare and more. Element Biosciences , $277M, biotech: It’s hard to get through a week without a big biotech raise, and this one’s no different. million this year, per Crunchbase data. based companies?
We organize all of the trending information in your field so you don't have to. Join 49,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content